Africa

Ebola’s Vaccine Trial Enters New Territory
Two vaccines specifically designed against Bundibugyo virus have been recommended for inclusion in the Democratic Republic of the Congo’s ongoing Ebola trial. Oxford’s ChAdOx1 candidate and Moderna’s mRNA-1469 could move the response beyond reliance on a vaccine developed for a different Ebola virus. Regulatory approval is still required. This is a scientific breakthrough in the…

Outbreaks Ignore Borders.

Five Outbreaks Closed. Polio Isn’t.

Ebola Is Killing People Before The System Finds Them.

The weight came back. Some visceral fat did not. Obesity care may be measuring the wrong outcome

Ebola Has Passed 2,000 Cases. The Response Is Still Chasing It.

Ebola May Be Reaching Kisangani. Containment Cannot Stay Provincial.

Mpox Reached Guinea-Bissau. Stigma Must Not Win.

South Sudan Has a New Health Deal. Now It Needs a Delivery System.

Gonorrhoea Is Not Disappearing. Too Many Systems Are Failing to See It.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
